Emmaus Life Sciences, Inc. vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $12 M for Emmaus Life Sciences, Inc., 7511 times as much (market caps of Jul 30, 2023 for Emmaus Life Sciences, Inc. and Oct 30, 2026 for Moderna, Inc.). Emmaus Life Sciences, Inc.'s value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
- Moderna, Inc. had more revenue: $1.9 B against $12 M for Emmaus Life Sciences, Inc., both in the year to December 2025.
- Both made a net loss: $7 M for Emmaus Life Sciences, Inc. and $2.8 B for Moderna, Inc.
- Emmaus Life Sciences, Inc. keeps more of each dollar of sales: a net margin of -60.2% against -145.2% for Moderna, Inc.
- Moderna, Inc. employs more people: 4,700 against 33 at Emmaus Life Sciences, Inc. Each employee brings in about $377,273 of revenue at Emmaus Life Sciences, Inc. and $413,617 at Moderna, Inc.
- Emmaus Life Sciences, Inc.'s revenue grew faster in its latest fiscal year: -25.2% against -39.9% for Moderna, Inc.
- On the Piotroski F-score, a nine-point test of improving finances, Emmaus Life Sciences, Inc. scores 3 and Moderna, Inc. 3.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Emmaus Life Sciences, Inc. EMMA | Moderna, Inc. MRNA · #274 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 2010 |
| Size | ||
| Market cap | $12 M* | $90.1 B |
| Revenue | $12 M | $1.9 B |
| Net income | $-7 M▲ best | $-2.8 B |
| Employees | 33 | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | — | 10.4× |
| Free cash flow yield | — | -2.3% |
| Profitability | ||
| Gross margin | 93.2%▲ best | 55.4% |
| Operating margin | 1.9%▲ best | -158.1% |
| Net margin | -60.2%▲ best | -145.2% |
| Return on equity | — | -28.9% |
| Growth | ||
| Revenue growth | -25.2%▲ best | -39.9% |
| Revenue growth, 3 years a year | -12.2%▲ best | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Net debt to EBITDA | 92.6× | — |
| Interest cover | 0.0× | — |
| Cash | ||
| Free cash flow margin | -0.1%▲ best | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | 3 of 9 | 3 of 9▲ best |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Jul 2023; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Emmaus Life Sciences, Inc. or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $12 M for Emmaus Life Sciences, Inc., 7511 times as much (market caps of Jul 30, 2023 for Emmaus Life Sciences, Inc. and Oct 30, 2026 for Moderna, Inc.). Emmaus Life Sciences, Inc.'s value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
Which makes more money, Emmaus Life Sciences, Inc. or Moderna, Inc.?
Moderna, Inc. had more revenue: $1.9 B against $12 M for Emmaus Life Sciences, Inc., both in the year to December 2025. Both made a net loss: $7 M for Emmaus Life Sciences, Inc. and $2.8 B for Moderna, Inc.
Which is more profitable, Emmaus Life Sciences, Inc. or Moderna, Inc.?
Emmaus Life Sciences, Inc. keeps more of each dollar of sales: a net margin of -60.2% against -145.2% for Moderna, Inc.
Which has more employees, Emmaus Life Sciences, Inc. or Moderna, Inc.?
Moderna, Inc. employs more people: 4,700 against 33 at Emmaus Life Sciences, Inc. Each employee brings in about $377,273 of revenue at Emmaus Life Sciences, Inc. and $413,617 at Moderna, Inc.
Which is growing faster, Emmaus Life Sciences, Inc. or Moderna, Inc.?
Emmaus Life Sciences, Inc.'s revenue grew faster in its latest fiscal year: -25.2% against -39.9% for Moderna, Inc.
Which is financially stronger, Emmaus Life Sciences, Inc. or Moderna, Inc.?
On the Piotroski F-score, a nine-point test of improving finances, Emmaus Life Sciences, Inc. scores 3 and Moderna, Inc. 3.